BioTricity Inc. Files Q3 2024 10-Q Report

Ticker: BTCY · Form: 10-Q · Filed: Feb 19, 2025 · CIK: 1630113

Sentiment: neutral

Topics: 10-Q, financials, medical-devices

TL;DR

BioTricity's Q3 10-Q is in. Check financials for the medical device maker.

AI Summary

BioTricity Inc. filed its 10-Q for the period ending December 31, 2024, reporting on its financial performance for the third quarter. The company, previously known as MetaSolutions, Inc., is incorporated in Nevada and operates in the surgical and medical instruments sector. Its principal executive offices are located in Redwood City, California.

Why It Matters

This filing provides investors and stakeholders with an update on BioTricity's financial health and operational status for the third quarter of fiscal year 2025.

Risk Assessment

Risk Level: medium — As a 10-Q filing, it contains detailed financial information that requires careful analysis to assess the company's risk profile.

Key Numbers

Key Players & Entities

FAQ

What is the reporting period for this 10-Q filing?

The Conformed Period of Report is 20241231, indicating the period ending December 31, 2024.

When was this 10-Q filed with the SEC?

The filing date (FILED AS OF DATE) is 20250219.

What is the company's primary business sector?

The Standard Industrial Classification (SIC) code is 3841, which corresponds to SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

What was the company's former name?

The former company name was METASOLUTIONS, INC., with a date of name change on 20150107.

Where is BioTricity Inc. headquartered?

The company's business address is 203 REDWOOD PARKWAY, SUITE 600, REDWOOD CITY, CA 94065.

Filing Details

This Form 10-Q (Form 10-Q) was filed with the SEC on February 19, 2025 regarding BIOTRICITY INC. (BTCY).

View full filing on EDGAR

View Full Filing

View this 10-Q filing on SEC EDGAR

View on Read The Filing